Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

HomeCirculationVol. 140, No. 6Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Free AccessCorrectionPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCorrectionPDF/EPUBCorrection to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Originally published5 Aug 2019https://doi.org/10.1161/CIR.0000000000000719Circulation. 2019;140:e285In the article by January et al, “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society,” which published ahead of print on January 28, 2019, and appeared in the July 9, 2019, issue of the journal (Circulation. 2019;140:e125–e151. doi: 10.1161/CIR.0000000000000665), a correction was needed.On the Title page, in the list of writing group members, an asterisk has been removed from the entry for Cynthia M. Tracy, MD, FAHA. The asterisk is associated with the following note: “*Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.”This correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIR.0000000000000665. Previous Back to top Next FiguresReferencesRelatedDetailsCited By Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, Naito S, Yamane T, Kimura M, Shiga T, Soejima K, Noda T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Kohsaka S and Mitamura H (2022) JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias, Circulation Journal, 10.1253/circj.CJ-21-0162, 86:2, (337-363), Online publication date: 25-Jan-2022. 宋 文 (2022) The Value of Electrocardiographic Parameters in Predicting Non-Valvular Atrial Fibrillation-Related Stroke, Advances in Clinical Medicine, 10.12677/ACM.2022.125616, 12:05, (4257-4263), . Jian B, Li Z, Wang J and Zhang C (2022) Correlation analysis between heart rate variability, epicardial fat thickness, visfatin and AF recurrence post radiofrequency ablation, BMC Cardiovascular Disorders, 10.1186/s12872-022-02496-x, 22:1, Online publication date: 1-Dec-2022. Farjat A, Virdone S, Thomas L, Kakkar A, Pieper K and Piccini J (2022) The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries, American Heart Journal, 10.1016/j.ahj.2021.09.003, 243, (110-121), Online publication date: 1-Jan-2022. Shaheed T, Martinez J, Frugoli A, Zane Smith W, Cahatol I and Fatemi O (2022) Determinants of postoperative atrial fibrillation: A retrospective evaluation of postoperative atrial fibrillation in cardiac surgery, Osteopathic Family Physician, 10.33181/13062, (10-18), Online publication date: 1-Jan-2022. Khaniukov O and Bucharskyi O (2022) FEATURES OF DIAGNOSIS OF AGE-OLD HYPOGONADISM IN MEN WITH CORONARY ARTERY DISEASE, Bulletin of Problems Biology and Medicine, 10.29254/2077-4214-2022-1-163-172-176, 1:1, (172), . Takatsuki S (2021) Are We Ready for the Upcoming Super-Aging Society?, Circulation Journal, 10.1253/circj.CJ-21-0274, 85:8, (1263-1264), Online publication date: 21-Jul-2021. White E and Coons J (2021) Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure, Current Cardiology Reports, 10.1007/s11886-021-01456-9, 23:4, Online publication date: 1-Apr-2021. Li X, Tang X and Li L (2021) Antipsychotics cardiotoxicity: What's known and what's next, World Journal of Psychiatry, 10.5498/wjp.v11.i10.736, 11:10, (736-753), Online publication date: 19-Oct-2021. Yan T, Zhu S, Zhu M, Zhu K, Dong L, Wang C and Guo C (2021) Clinical Performance of a Powered Surgical Stapler for Left Atrial Appendage Resection in a Video-Assisted Thoracoscopic Ablation for Patients with Nonvalvular Atrial Fibrillation, International Heart Journal, 10.1536/ihj.20-765, 62:4, (764-770), Online publication date: 30-Jul-2021. Chua W, Roth Cardoso V, Guasch E, Sinner M, Brady P, Casadei B, Crijns H, Dudink E, Hatem S, Kääb S, Kastner P, Mont L, Nehaj F, Purmah Y, Reyat J, Schotten U, Zeemering S, Ziegler A, Gkoutos G, Kirchhof P and Fabritz L A Novel Biomarker Model for Detecting Patients With Atrial Fibrillation: A Development and Validation Study, SSRN Electronic Journal, 10.2139/ssrn.3777185 Nam J, Kim C, Lee Y, Jung D, Gwak H and Chung J (2021) Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis, Korean Journal of Clinical Pharmacy, 10.24304/kjcp.2021.31.2.87, 31:2, (87-95), Online publication date: 30-Jun-2021. Ching C, Leong B, Nair P, Chan K, Seow E, Lee F, Heng K, Sewa D, Lim T, Chong D, Yeo K, Fong W, Anantharaman V and Lim S (2021) Singapore Advanced Cardiac Life Support Guidelines 2021, Singapore Medical Journal, 10.11622/smedj.2021109, 62:08, (390-403), Online publication date: 31-Aug-2021. Musat D and Mittal S (2021) Atrial fibrillation ablation – from surgery to radiofrequency, cryo and beyond, Romanian Journal of Cardiology, 10.47803/rjc.2020.30.4.553, 30:4, (553-570), Online publication date: 4-Jan-2021. Yamashita T, Nakasu Y, Mizutani H and Sumitani K (2021) Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure ― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―, Circulation Reports, 10.1253/circrep.CR-20-0119, 3:1, (34-43), Online publication date: 8-Jan-2021. Kolhe M, Gilhotra R and Asane G (2021) Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol, Research Journal of Pharmacy and Technology, 10.52711/0974-360X.2021.00393, (2216-2220), Online publication date: 29-Apr-2021. Narita N, Okumura K, Kinjo T, Mikami J, Tsushima K, Takahashi R, Noro M, Hashimoto A, Sasaki T, Takaki M, Ishidoya E, Narita Y, Imai H, Ono E and Tomita H (2020) Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region ― Analysis Using the National Health Insurance Database ―, Circulation Journal, 10.1253/circj.CJ-18-0989, 84:5, (706-713), Online publication date: 24-Apr-2020. TANISAWA H, AKUTSU Y, ITO H, NOMURA K, SEKIMOTO T, KANEKO K, KODAMA Y, ARAI K, GOKAN T, ONISHI Y, OCHI A, MUNETSUGU Y, ONUKI T, OHGIYA Y, MATSUMOTO H, KAWAMURA M and SHINKE T (2020) Epicardial Adipose Tissue in the Right Atrium Is Associated with Progression of Atrial Fibrillation and Recurrence after Pulmonary Vein Catheter Ablation in Patients with Atrial Fibrillation, The Showa University Journal of Medical Sciences, 10.15369/sujms.32.11, 32:1, (11-24), . Truong S, Cong C and Weng R (2020) The Potential of Andexanet Alfa as a Reversal Agent for Direct Oral Anticoagulants, Medical Journal of Southern California Clinicians, 10.38206/130108, (44-47), Online publication date: 31-May-2020. Tiew W, Wong V, Tan V, Tan Y and Lee E (2020) A Real-world Experience of the Safety and Efficacy of Non-vitamin K Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation— A Single-centre Retrospective Cohort Study in Singapore, Annals of the Academy of Medicine, Singapore, 10.47102/annals-acadmedsg.2020184, 49:11, (838-847), Online publication date: 30-Nov-2020. Margarit J, Pajares M, Garcia Camacho C, Castaño Ruiz M, Gómez M, García Suárez J, Soto M, López Meléndez J, Martín Gutiérrez E, Blanco Morillo J, Mateo E, Hernández Acuña C, Vives M, Llorens R, Fernández Cruz J, Acosta J, Pradas Irún C, García M, Aguilar Blanco E, Castaño B, López S, Bel A, Gabaldón T, Fernández López A, Gutiérrez Carretero E, López Forte C, Moreno J, Galán J, Osseyran F, Bustamante J, Veiras S and Vicente R (2020) Guidelines for enhanced recovery after cardiac surgery. Consensus document of Spanish Societies of Anesthesia (SEDAR), Cardiovascular Surgery (SECCE) and Perfusionists (AEP), Revista Española de Perfusión, 10.36579/rep.2020.Supl:Supplement, (5-77), Online publication date: 30-Dec-2021. Mujer M, Rai M, Atti V, Dimaandal I, Chan A, Shrotriya S, Gundabolu K and Dhakal P (2020) An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants, Advances in Hematology, 10.1155/2020/7636104, 2020, (1-10), Online publication date: 27-Jan-2020. Hu Y, Cheng W, Hung Y, Lin W, Chao T, Liao J, Lin Y, Lin W, Chen Y and Chen S (2020) Management of Atrial Fibrillation in COVID-19 Pandemic, Circulation Journal, 10.1253/circj.CJ-20-0566, 84:10, (1679-1685), Online publication date: 25-Sep-2020. Martymianova L, Tykhonova T, Bychkova O, Lysenko N and Barabash N (2020) GENERAL CARDIOVASCULAR RISK AND FUNCTIONAL INDICATORS OF THE PERMANENT ATRIAL FIBRILLATION, Wiadomości Lekarskie, 10.36740/WLek201912113, 72:12, Online publication date: 1-Dec-2019. Woodhouse A, Burke M and Misher A (2019) Direct Oral Anticoagulant (DOAC) to Warfarin Transitions in a Pharmacist-led Anticoagulation Clinic, Journal of Contemporary Pharmacy Practice, 10.37901/jcphp17-00024, 66:1, (48-51), Online publication date: 1-Mar-2019. (2020) Use of SAMe-TT₂R₂ Score to Predict the Quality of Anticoagulation Control in Patients with Atrial Fibrillation Receiving Warfarin in Thailand, Journal of the Medical Association of Thailand, 10.35755/jmedassocthai.2020.06.10827, 103:6, (548-552) Stacy J, Kim R, Barrett C, Sekar B, Simon S, Banaei-Kashani F and Rosenberg M (2022) Qualitative Evaluation of an Artificial Intelligence-based Clinical Decision Support System to Guide Rhythm Management of Atrial Fibrillation: A Survey Study (Preprint), JMIR Formative Research, 10.2196/36443 Tavares L, Lador A and Valderrábano M (2021) Sleep Apnea and Atrial Fibrillation: Role of the Cardiac Autonomic Nervous System, Methodist DeBakey Cardiovascular Journal, 10.14797/ZYUT2951, 17:1, (48) ÖZYURTLU F and ÇETİN N (2020) Nonvalvüler Atriyal Fibrilasyon Hastalarında Dabigatran Tedavisinin Trombosit Hacim İndeksleri ve Trombosit Sayısı Üzerine Etkileri, Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 10.34087/cbusbed.710032 Gusev V, Lvova O and Shamalov N (2021) Problems of selecting an anticoagulant for secondary stroke prevention in patients with atrial fibrillation, Cardiovascular Therapy and Prevention, 10.15829/1728-8800-2021-3044, 20:6, (3044) Kanorskii S (2021) Atrial fibrillation treatment in Russia: work on bugs, Journal of Arrhythmology, 10.35336/VA-2021-3-e1-e4, 28:3, (1-4) Verma M, Terricabras M and Verma A (2021) The Cutting Edge of Atrial Fibrillation Ablation, Arrhythmia & Electrophysiology Review, 10.15420/aer.2020.40, 10:2, (101-107) Zolotovskaya I, Sabanova V and Davydkin I (2021) The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2021-04-17, 17:2, (294-302) Azenkot T, Chatterton B and Schwarz E (2022) Anticoagulant Prescriptions Provided in US Ambulatory Practice, 2014 to 2016, Journal of General Internal Medicine, 10.1007/s11606-022-07536-y Novikova Т (2021) The risk of bleeding minimization with direct oral anticoagulants, Aterotromboz = Atherothrombosis, 10.21518/2307-1109-2021-11-1-106-126:1, (106-126) Kanorskii S (2021) Atrial fibrillation in old age: risk management and features of the use of direct oral anticoagulants, Kardiologiia, 10.18087/cardio.2021.6.n1627, 61:6, (79-87) Bitar Y, Duraes A, Roever L, Gomes Neto M, Lins-Kusterer L and Bocchi E (2021) Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.712585, 8 Zolotovskaya I, Sabanova V and Davydkin I (2021) Potential for anticoagulant therapy in the most vulnerable groups of patients, Russian Journal of Cardiology, 10.15829/1560-4071-2021-4786, 26:4S, (4786) Yan T, Zhu S, Shi Y, Xie C, Zhu M, Zhang Y, Wang C and Guo C (2021) Pan-Cancer Analysis of Atrial-Fibrillation-Related Innate Immunity Gene ANXA4, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.713983, 8 Meng X and Xu X (2020) What Is the Ideal Blood Pressure Treatment Target for Primary Prevention and Management of Atrial Fibrillation?, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2020.586183, 7 Kropacheva E, Krivosheeva E and Panchenko E (2021) Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)), Aterotromboz = Atherothrombosis, 10.21518/2307-1109-2021-1-68-88:1, (68-88) Larina V, Oynotkinova O, Majorova A, Egiazarian G and Demidova T (2021) An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2021-06-05, 17:3, (484-491) Kavousi M (2020) Differences in Epidemiology and Risk Factors for Atrial Fibrillation Between Women and Men, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2020.00003, 7 Choi J, Kim W, Kim Y, Cho J, Shin S, Kim C and Kim J (2022) Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.849474, 9 Chong D, Andreotti F, Verhamme P, Dalal J, Uaprasert N, Wang C, On Y, Li Y, Jiang J, Hasegawa K, Almuti K, Bai R, Lo S, Krittayaphong R, Lee L, Quek D, Johar S, Seow S, Hammett C and Tan J (2021) Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management, European Cardiology Review, 10.15420/ecr.2020.43, 16 Ebai F and Mohiuddin A (2021) Failure of non-vitamin K antagonist oral anticoagulants in preventing stroke in elderly patient: a case report of multiple strokes on standard of care treatment for atrial fibrillation, Archive of Clinical Cases, 10.22551/2021.30.0801.10177, 8:1, (1-6) Archakov E, Batalov R, Usenkov S and Popov S (2021) The experience of using non-invasive long-term ECG monitoring in patients with various cardiac arrhythmias, The Siberian Journal of Clinical and Experimental Medicine, 10.29001/2073-8552-2021-36-3-166-172, 36:3, (166-172) Sorokoumov V (2022) Anticoagulant therapy for the prevention of recurrent stroke in patients with atrial fibrillation: a comprehensive risk management, Cardiovascular Therapy and Prevention, 10.15829/1728-8800-2022-3122, 21:1, (3122) Kea B, Waites B, Lin A, Raitt M, Vinson D, Ari N, Welle L, Sill A, Button D and Sun B (2020) Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge, Western Journal of Emergency Medicine, 10.5811/westjem.2020.3.45135, 21:4 Mazur E, Mazur V, Bazhenov N and Orlov Y (2021) Risk of Cardiovascular Complications in Patients with Persistent Atrial Fibrillation after Dissolution of a Thrombus in the Left Atrial Appendage, Kardiologiia, 10.18087/cardio.2021.5.n1463, 61:5, (17-22) Zagidullin N and Davtyan P (2021) Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease, Russian Journal of Cardiology, 10.15829/1560-4071-2021-4676, 26:3S, (4676) Obrezan A, Filippov A and Obrezan A (2021) A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen, Russian Journal of Cardiology, 10.15829/1560-4071-2021-4508, 26:5, (4508) Belenkov Y, Popova L and Ilgisonis S (2021) Management of patients with atrial fibrillation and minor bleeding during therapy with direct oral anti-coagulants, Kardiologiia, 10.18087/cardio.2021.12.n1872, 61:12, (72-81) Yan T, Zhu S, Zhu M, Wang C and Guo C (2021) Integrative Identification of Hub Genes Associated With Immune Cells in Atrial Fibrillation Using Weighted Gene Correlation Network Analysis, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2020.631775, 7 August 6, 2019Vol 140, Issue 6 Advertisement Article InformationMetrics © 2019 American Heart Association, Inc.https://doi.org/10.1161/CIR.0000000000000719PMID: 31381421 Manuscript receivedJuly 2, 2019Manuscript acceptedJuly 2, 2019Originally publishedAugust 5, 2019 PDF download Advertisement